MaxCyte, Inc. Increase Decrease In Operating Lease Liability
MaxCyte, Inc. (MXCT) reported Increase Decrease In Operating Lease Liability of -$692.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- MaxCyte, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$236.00K.
- MaxCyte, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$456.00K.
- MaxCyte, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$218.00K.
- MaxCyte, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$346.00K.
- MaxCyte, Inc. increase decrease in operating lease liability for fiscal 2025 was -$1.16M.
- MaxCyte, Inc. increase decrease in operating lease liability for fiscal 2024 was -$709.00K.
- MaxCyte, Inc. increase decrease in operating lease liability for fiscal 2023 was -$133.00K, a 102.43% decline from fiscal 2022.
- MaxCyte, Inc. increase decrease in operating lease liability for fiscal 2022 was $5.48M, a 41.47% increase from fiscal 2021.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 3 month as first filed | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 6 month as first filed | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 9 month as first filed | Increase Decrease In Operating Lease Liability 12 month | Increase Decrease In Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$236.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$692.00K 10-Q · filed 2026-08-13 | -$910.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.26M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | -$456.00K 10-Q · filed 2026-05-13 | -$674.00K derived: sum of 2 quarters · filed 2026-05-13 | -$1.02M derived: sum of 3 quarters · filed 2026-05-13 | -$1.33M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$564.00K derived: sum of 2 quarters · filed 2026-03-25 | -$879.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.16M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | -$346.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$661.00K derived: sum of 2 quarters · filed 2026-08-13 | -$939.00K 10-Q · filed 2025-11-13 | -$1.22M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | -$315.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$593.00K 10-Q · filed 2026-08-13 | -$878.00K derived: sum of 3 quarters · filed 2026-08-13 | -$1.09M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | -$278.00K 10-Q · filed 2026-05-13 | -$563.00K derived: sum of 2 quarters · filed 2026-05-13 | -$772.00K derived: sum of 3 quarters · filed 2026-05-13 | -$884.00K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$285.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$494.00K derived: sum of 2 quarters · filed 2026-03-25 | -$606.00K derived: sum of 3 quarters · filed 2026-03-25 | -$709.00K 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | -$209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$321.00K derived: sum of 2 quarters · filed 2025-11-13 | -$424.00K 10-Q · filed 2025-11-13 | -$544.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$215.00K 10-Q · filed 2025-08-06 | -$335.00K derived: sum of 3 quarters · filed 2025-08-06 | -$460.00K derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | -$103.00K 10-Q · filed 2025-05-08 | -$223.00K derived: sum of 2 quarters · filed 2025-05-08 | -$348.00K derived: sum of 3 quarters · filed 2025-05-08 | -$393.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$120.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$245.00K derived: sum of 2 quarters · filed 2025-03-11 | -$290.00K derived: sum of 3 quarters · filed 2025-03-11 | -$133.00K 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | -$125.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$170.00K derived: sum of 2 quarters · filed 2024-11-06 | -$13.00K 10-Q · filed 2024-11-06 | -$12.80K 10-Q · filed 2023-11-08 | -$3.87M derived: sum of 4 quarters · filed 2024-11-06 | |||
| 2023-06-30 | -$45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $112.00K 10-Q · filed 2024-08-06 | $111.80K 10-Q · filed 2023-08-09 | -$3.75M derived: sum of 3 quarters · filed 2024-08-06 | -$3.22M derived: sum of 4 quarters · filed 2024-08-06 | |||
| 2023-03-31 | $157.00K 10-Q · filed 2024-05-07 | $157.50K 10-Q · filed 2023-05-10 | -$3.70M derived: sum of 2 quarters · filed 2024-05-07 | -$3.17M derived: sum of 3 quarters · filed 2024-05-07 | -$1.93M derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | -$3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$3.33M derived: sum of 2 quarters · filed 2024-03-12 | -$2.09M derived: sum of 3 quarters · filed 2024-03-12 | $5.48M 10-K · filed 2024-03-12 | $10.41M 10-K · filed 2023-03-15 | |||
| 2022-09-30 | $532.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.77M derived: sum of 2 quarters · filed 2023-11-08 | $9.34M 10-Q · filed 2023-11-08 | $13.95M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $8.81M 10-Q · filed 2023-08-09 | $13.42M derived: sum of 3 quarters · filed 2023-08-09 | $13.27M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $7.57M 10-Q · filed 2023-05-10 | $12.18M derived: sum of 2 quarters · filed 2023-05-10 | $12.03M derived: sum of 3 quarters · filed 2023-05-10 | $11.58M derived: sum of 4 quarters · filed 2023-05-10 | ||||
| 2021-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $4.46M derived: sum of 2 quarters · filed 2023-03-15 | $4.01M derived: sum of 3 quarters · filed 2023-03-15 | $3.87M 10-K · filed 2023-03-15 | ||||
| 2021-09-30 | -$150.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$597.10K derived: sum of 2 quarters · filed 2022-11-09 | -$734.70K 10-Q · filed 2022-11-09 | -$964.90K derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$446.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$584.00K 10-Q · filed 2022-08-10 | -$814.20K derived: sum of 3 quarters · filed 2022-08-10 | -$844.00K derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | -$137.60K 10-Q · filed 2022-05-09 | -$367.80K derived: sum of 2 quarters · filed 2022-05-09 | -$397.60K derived: sum of 3 quarters · filed 2022-05-09 | |||||
| 2020-12-31 | -$230.20K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | -$260.00K derived: sum of 2 quarters · filed 2022-03-22 | -$508.80K 10-K · filed 2022-03-22 | |||||
| 2020-09-30 | -$29.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$278.60K 10-Q · filed 2021-11-10 | ||||||
| 2020-06-30 | -$248.80K 10-Q · filed 2021-09-13 | |||||||
| 2019-12-31 | $68.60K 10-K · filed 2022-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |